SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-16-000559
Filing Date
2016-02-09
Accepted
2016-02-09 14:26:29
Documents
1
Group Members
CLARUS VENTURES III GP L.P.CLARUS VENTURES III LLCDENNIS HENNERKURT WHEELERNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAKSCOTT REQUADT

Document Format Files

Seq Description Document Type Size
1 NEOTHETICS, INC. - AMENDMENT #1 clarusiii-neosch13g_17901.htm SC 13G/A 94216
  Complete submission text file 0001072613-16-000559.txt   95987
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Filed by) CIK: 0001597143 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1214
Type: SC 13G/A

Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 270 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 270 SAN DIEGO CA 92122 (858) 750-1008
Neothetics, Inc. (Subject) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88576 | Film No.: 161398800
SIC: 2834 Pharmaceutical Preparations